Total Payments
$31,052
2024 Payments
$2,792
Companies
41
Transactions
705
Medicare Patients
599
Medicare Billing
$70,890
Payment Breakdown by Category
Food & Beverage$20,514 (66.1%)
Consulting$9,419 (30.3%)
Travel$1,060 (3.4%)
Education$59.00 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,514 | 685 | 66.1% |
| Consulting Fee | $9,419 | 5 | 30.3% |
| Travel and Lodging | $1,060 | 5 | 3.4% |
| Education | $59.00 | 10 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $14,781 | 132 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,496 | 106 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,260 | 71 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,653 | 42 | $0 (2024) |
| Lilly USA, LLC | $1,463 | 56 | $0 (2023) |
| Novo Nordisk Inc | $1,316 | 49 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,109 | 61 | $0 (2024) |
| Esperion Therapeutics, Inc. | $877.20 | 19 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $721.96 | 30 | $0 (2024) |
| Amgen Inc. | $627.31 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,792 | 78 | GlaxoSmithKline, LLC. ($423.97) |
| 2023 | $2,159 | 68 | Gilead Sciences, Inc. ($625.57) |
| 2022 | $2,673 | 80 | AstraZeneca Pharmaceuticals LP ($598.81) |
| 2021 | $2,525 | 95 | Esperion Therapeutics, Inc. ($578.50) |
| 2020 | $1,449 | 74 | Novo Nordisk Inc ($210.99) |
| 2019 | $6,136 | 110 | Gilead Sciences, Inc. ($3,734) |
| 2018 | $7,582 | 112 | Gilead Sciences, Inc. ($5,322) |
| 2017 | $5,735 | 88 | Gilead Sciences Inc ($3,977) |
All Payment Transactions
705 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.22 | General |
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.05 | General |
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: VACCINES | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $139.19 | General |
| Category: Bone Health | ||||||
| 10/15/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Oncology | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $124.39 | General |
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/04/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: VACCINE | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Respiratory | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 18 | 70 | $14,000 | $4,457 |
| 2022 | 6 | 106 | 213 | $41,160 | $15,888 |
| 2021 | 11 | 275 | 412 | $54,600 | $26,512 |
| 2020 | 10 | 200 | 411 | $52,394 | $24,033 |
Total Patients
599
Total Services
1,106
Medicare Billing
$70,890
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 70 | $14,000 | $4,457 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 130 | $26,000 | $8,250 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 30 | $7,500 | $3,190 | 42.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $3,600 | $2,368 | 65.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 19 | 19 | $2,850 | $1,345 | 47.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $550.00 | $388.91 | 70.7% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 11 | 11 | $660.00 | $346.24 | 52.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 166 | $30,750 | $12,788 | 41.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 39 | $9,000 | $4,238 | 47.1% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 79 | 79 | $5,530 | $3,764 | 68.1% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 19 | 19 | $2,850 | $1,634 | 57.3% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 26 | 26 | $1,820 | $1,239 | 68.1% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 16 | 16 | $1,600 | $762.24 | 47.6% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 15 | 15 | $750.00 | $714.60 | 95.3% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 12 | 12 | $720.00 | $571.68 | 79.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 15 | 15 | $450.00 | $336.75 | 74.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $650.00 | $264.94 | 40.8% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 12 | 12 | $480.00 | $198.54 | 41.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 195 | $29,250 | $12,261 | 41.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 55 | $11,000 | $5,038 | 45.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 26 | 29 | $4,350 | $2,521 | 58.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 13 | 13 | $2,430 | $1,759 | 72.4% |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 23 | 24 | $1,440 | $698.20 | 48.5% |
| 36410 | Insertion of needle into vein, patient 3 years or older | Office | 2020 | 23 | 34 | $1,464 | $563.71 | 38.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 24 | 25 | $1,250 | $492.95 | 39.4% |
About Dr. Wei Tan, MD
Dr. Wei Tan, MD is a Internal Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174511000.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wei Tan, MD has received a total of $31,052 in payments from pharmaceutical and medical device companies, with $2,792 received in 2024. These payments were reported across 705 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($20,514).
As a Medicare-enrolled provider, Tan has provided services to 599 Medicare beneficiaries, totaling 1,106 services with total Medicare billing of $70,890. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Brooklyn, NY
- Active Since 10/13/2005
- Last Updated 03/27/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174511000
Products in Payments
- Vemlidy (Drug) $12,005
- JARDIANCE (Drug) $1,613
- FARXIGA (Drug) $1,059
- Ozempic (Drug) $897.55
- BREZTRI (Drug) $645.49
- SHINGRIX (Biological) $615.48
- TRULICITY (Drug) $581.34
- NEXLIZET (Drug) $574.82
- Vascepa (Drug) $533.06
- AREXVY (Drug) $506.23
- XARELTO (Drug) $476.44
- XIFAXAN (Drug) $459.26
- SYMBICORT (Drug) $435.50
- FORTEO (Drug) $382.75
- Kerendia (Drug) $318.37
- NEXLETOL (Drug) $302.38
- TRELEGY ELLIPTA (Drug) $266.39
- JANUVIA (Drug) $265.89
- TRADJENTA (Drug) $228.46
- PNEUMOVAX 23 (Biological) $225.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brooklyn
Bruce Berger, M.d, M.D
Internal Medicine — Payments: $3.0M
Internal Medicine $3.0M
Dr. Jesi Ramone, Md, MD
Internal Medicine — Payments: $701,491
Internal Medicine $701,491
Dr. Ali El Atat, M.d, M.D
Internal Medicine — Payments: $426,309
Internal Medicine $426,309
Manish Parikh, Md, MD
Internal Medicine — Payments: $360,332
Internal Medicine $360,332
Dr. Samuel Uter, Md, MD
Internal Medicine — Payments: $238,375
Internal Medicine $238,375
Dr. Bharath Reddy, Md, MD
Internal Medicine — Payments: $159,733
Internal Medicine $159,733